Comparison of endothelial function in the carotid artery between normal and short-term hypercholesterolemic rabbits

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 144, Issue 2, 2006, Pages 197-203

  Moroe, Hiroko ^a   Honda, Hideo ^a,b  

^a SHOWA UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Carotid artery; Cytochrome P 450 monooxygenase; EDHF; Endothelium; Hypercholesterolemia; Nitric oxide; Rabbit; Relaxation

Indexed keywords

4 AMINOPYRIDINE; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ARGININE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CHARYBDOTOXIN; CHOLESTEROL; CYTOCHROME P450 3A; ENZYME INHIBITOR; GLIBENCLAMIDE; INDOMETACIN; KETOCONAZOLE; LIPID; NITRATE; NITROPRUSSIDE SODIUM; PROADIFEN; TETRYLAMMONIUM; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CHOLESTEROL DIET; CONTROLLED STUDY; DIETARY INTAKE; ENDOTHELIUM; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ORYCTOLAGUS CUNICULUS;

EID: 33750171558     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2006.08.011     Document Type: Article

References (39)

1. Adeagbo A.S., and Triggle C.R. Varying extracellular [K+]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 21 (1993) 423-429
2. Ampong B., Honda H., and Kogo H. Effect of hypothyroidism on beta-adrenoceptor-mediated relaxation in the rat thoracic aorta: a time-dependent study. Vasc. Pharmacol. 38 (2002) 149-155
3. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., and Busse R. Nitric oxide attenuates the release of endothelium-derived-hyperpolarizing factor. Circulation 94 (1996) 3341-3347
4. G-Nitro-l-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis 135 (1997) 49-55
5. Campbell W.B., Gebremedhin D., Pratt P.F., and Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78 (1996) 415-423
6. Chappell S.P., Lewis M.J., and Henderson A.H. Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations. Cardiovasc. Res. 21 (1987) 34-38
7. Chaytor A.T., Evans W.H., and Griffith T.M. Central role of heterocellular gap junctional communication in endothelium-dependent relaxation of rabbit arteries. J. Physiol. 508 (1988) 561-573
8. Cohen R.A., and Vanhoutte P.M. Endothelium-dependent hyperpolarization-beyond nitric oxide and cyclic GMP. Circulation 92 (1995) 3337-3349
9. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 19 (1998) 269-272
10. Ferreira S.H., Moncada S., and Vaine J.R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature 231 (1971) 233-239
11. Garcia M.L., Knaus H.G., Munujos P., Slaughter R.S., and Kaczorowski G.J. Charybdotoxin and its effects on potassium channels. Am. J. Physiol. 269 (1995) C1-C10
12. Hecker M., Bara A.T., Bauersachs J., and Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P-450-derived arachidonic acid metabolite in mammals. J. Physiol. 481 (1994) 407-414
13. Ca channel activator, NS1619, on rat cerebral artery smooth muscle. Br. J. Pharmacol. 117 (1996) 19-29
14. Honda H., Kaneko H., Kondo M., and Kogo H. Comparison of endothelium-derived relaxing activity between nonpregnant and pregnant rats. Comp. Biochem. Physiol. 114C (1996) 193-196
15. Honda H., Yamaguchi K., and Kogo H. 17beta-Estradiol alters isoproterenol-induced relaxation in rat aortic rings. Jpn. J. Pharmacol. 77 (1998) 311-313
16. Honda H., Unemoto T., and Kogo H. Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 34 (1999) 1232-1236
17. G-nitro-l-arginine- and indomethacin-resistant endothelium-dependent relaxation by acetylcholine in rabbit renal artery. Jpn. J. Pharmacol. 85 (2001) 203-206
18. Honda H., Moroe H., Fujii H., Arai K., Satoh J., Inamura T., Notoya, Hayashi T., and Kogo H. Short-term effects of hypercholesterolemia on endothelium-derived hyperpolarizing factor-dependent vasodilation. J. Vasc. Res. 38 Supp.1 (2001) 14
19. Honda H., Iwata T., Matsuda H., Moroe H., Kumasaka K., and Kondo M. Comparison of muscarinic receptor- and beta-adrenoceptor-mediated vasorelaxation between euthyroid and acute hypothyroid rats. Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. 141 (2005) 241-247
20. Honda H., Shibusaw Y., Taniguchi J., Matsuda H., Kondo M., Kumasaka K., Miwa T., Notoya Y., and Shindo H. Rapid and simple determination of epoxyeicosatrienoic acids in rabbit renal artery by reversed-phase HPLC with fluorescence detection. Vasc. Pharmacol. 42 (2005) 163-169
21. Iribarne C., Berthou F., Barthou F., Baird S., Dreano Y., Picard D., Bail J.P., Beaune P., and Menez J.F. Involvement of cytochrome P450 3A4 enzyme in the N-dimethyration of methadone in human liver microsomes. Chem. Res. Toxicol. 9 (1996) 365-373
22. G-Nitro-l-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol. 176 (1990) 219-223
23. Jayakody L., Senaratne M., Thomson A., and Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ. Res. 60 (1987) 251-264
24. Kristof A.S., Noorhosseini H., and Hussain S.N. Attenuation of endothelium-dependent hyperpolarizing factor by bacterial lipopolysaccharides. Eur. J. Pharmacol. 328 (1997) 69-73
25. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W., and Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315 (1986) 1046-1051
26. Mommbouli J.V., and Vanhotte P.M. Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol. Sci. 18 (1997) 252-256
27. 2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb. Res. 11 (1977) 323-344
28. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
29. Moroe H., Fujii H., Honda H., Arai K., Kanazawa M., Notoya Y., and Kogo H. Characterization of endothelium-dependent relaxation and modulation by treatment with pioglitazone in the hypercholesterolemic rabbit renal artery. Eur. J. Pharmacol. 497 (2004) 317-325
30. Najibi S., and Cohen R.A. Enhanced role of potassium channels in relaxations of hypercholesterolemic rabbit carotid artery to NO. Am. J. Physiol. 269 (1995) H805-H811
31. Randall M.D., Alexander S.P., Bennett T., Boyd E.A., Fry J.R., Gardiner S.M., Kemp P.A., McCulloch A.I., and Kendall D.A. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun. 229 (1996) 114-120
32. Senciall I.R., Rahal S.R., and Roberts R. Ketoconazole inhibition of progesterone oxidation by the rabbit. Biochem. Pharmacol. 37 (1988) 3647-3651
33. Spagnoli L.G., Villaschi S., Neri L., and Palmieri G. Gap junctions in myo-endothelial bridges of rabbit carotid arteries. Experientia 38 (1982) 124-125
34. + channels in arterial smooth muscle. Science 245 (1989) 177-180
35. Taniguchi J., Honda H., Shibusaw Y., Iwata T., and Notoya Y. Alteration in endothelial function and modulation by treatment with pioglitazone in rabbit renal artery from short-term hypercholesterolemia. Vasc. Pharmacol. 43 (2005) 47-55
36. Taylor S.G., and Weston A.H. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci. 9 (1988) 272-274
37. Taylor H.J., Chaytor A.T., Edwards D.H., and Griffith T.M. Gap junction-dependent increases in smooth muscle cAMP underpin the EDHF phenomenin in rabbit arteries. Biochem. Biophys. Res. Commun. 28 (2001) 583-589
38. Unemoto T., Honda H., and Kogo H. Differences in the mechanisms for relaxation of aorta induced by 17beta-estradiol or progesterone between normotensive and hypertensive rats. Eur. J. Pharmacol. 472 (2003) 119-126
39. Verbeuren T.J., Jordaens F.H., Van Hove C.E., Van Hoydonck A.E., and Herman A.G. Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta. Eur. J. Pharmacol. 191 (1990) 173-184